sentence
stringlengths 3
630
| entities
listlengths 0
10
|
|---|---|
Identification of APC2 , a homologue of the adenomatous polyposis coli tumour suppressor .
|
[
{
"offsets": [
44,
77
],
"text": "adenomatous polyposis coli tumour",
"type": "Disease"
}
] |
The adenomatous polyposis coli ( APC ) tumour - suppressor protein controls the Wnt signalling pathway by forming a complex with glycogen synthase kinase 3beta ( GSK - 3beta ) , axin / conductin and betacatenin .
|
[
{
"offsets": [
4,
45
],
"text": "adenomatous polyposis coli ( APC ) tumour",
"type": "Disease"
}
] |
Complex formation induces the rapid degradation of betacatenin .
|
[] |
In colon carcinoma cells , loss of APC leads to the accumulation of betacatenin in the nucleus , where it binds to and activates the Tcf - 4 transcription factor ( reviewed in [ 1 ] [ 2 ] ) .
|
[
{
"offsets": [
3,
18
],
"text": "colon carcinoma",
"type": "Disease"
}
] |
Here , we report the identification and genomic structure of APC homologues .
|
[] |
Mammalian APC2 , which closely resembles APC in overall domain structure , was functionally analyzed and shown to contain two SAMP domains , both of which are required for binding to conductin .
|
[] |
Like APC , APC2 regulates the formation of active betacatenin - Tcf complexes , as demonstrated using transient transcriptional activation assays in APC - / - colon carcinoma cells .
|
[
{
"offsets": [
159,
174
],
"text": "colon carcinoma",
"type": "Disease"
}
] |
Human APC2 maps to chromosome 19p13 .
|
[] |
3 .
|
[] |
APC and APC2 may therefore have comparable functions in development and cancer .
|
[
{
"offsets": [
72,
78
],
"text": "cancer",
"type": "Disease"
}
] |
A common MSH2 mutation in English and North American HNPCC families : origin , phenotypic expression , and sex specific differences in colorectal cancer .
|
[
{
"offsets": [
53,
58
],
"text": "HNPCC",
"type": "Disease"
},
{
"offsets": [
135,
152
],
"text": "colorectal cancer",
"type": "Disease"
}
] |
The frequency , origin , and phenotypic expression of a germline MSH2 gene mutation previously identified in seven kindreds with hereditary non - polyposis cancer syndrome ( HNPCC ) was investigated .
|
[
{
"offsets": [
129,
171
],
"text": "hereditary non - polyposis cancer syndrome",
"type": "Disease"
},
{
"offsets": [
174,
179
],
"text": "HNPCC",
"type": "Disease"
}
] |
The mutation ( A - - > T at nt943 + 3 ) disrupts the 3 splice site of exon 5 leading to the deletion of this exon from MSH2 mRNA and represents the only frequent MSH2 mutation so far reported .
|
[] |
Although this mutation was initially detected in four of 33 colorectal cancer families analysed from eastern England , more extensive analysis has reduced the frequency to four of 52 ( 8 % ) English HNPCC kindreds analysed .
|
[
{
"offsets": [
60,
77
],
"text": "colorectal cancer",
"type": "Disease"
},
{
"offsets": [
199,
204
],
"text": "HNPCC",
"type": "Disease"
}
] |
In contrast , the MSH2 mutation was identified in 10 of 20 ( 50 % ) separately identified colorectal families from Newfoundland .
|
[
{
"offsets": [
90,
100
],
"text": "colorectal",
"type": "Disease"
}
] |
To investigate the origin of this mutation in colorectal cancer families from England ( n = 4 ) , Newfoundland ( n = 10 ) , and the United States ( n = 3 ) , haplotype analysis using microsatellite markers linked to MSH2 was performed .
|
[
{
"offsets": [
46,
63
],
"text": "colorectal cancer",
"type": "Disease"
}
] |
Within the English and US families there was little evidence for a recent common origin of the MSH2 splice site mutation in most families .
|
[] |
In contrast , a common haplotype was identified at the two flanking markers ( CA5 and D2S288 ) in eight of the Newfoundland families .
|
[] |
These findings suggested a founder effect within Newfoundland similar to that reported by others for two MLH1 mutations in Finnish HNPCC families .
|
[
{
"offsets": [
131,
136
],
"text": "HNPCC",
"type": "Disease"
}
] |
We calculated age related risks of all , colorectal , endometrial , and ovarian cancers in nt943 + 3 A - - > T MSH2 mutation carriers ( n = 76 ) for all patients and for men and women separately .
|
[
{
"offsets": [
41,
87
],
"text": "colorectal , endometrial , and ovarian cancers",
"type": "Disease"
}
] |
For both sexes combined , the penetrances at age 60 years for all cancers and for colorectal cancer were 0 .
|
[
{
"offsets": [
66,
73
],
"text": "cancers",
"type": "Disease"
},
{
"offsets": [
82,
99
],
"text": "colorectal cancer",
"type": "Disease"
}
] |
86 and 0 .
|
[] |
57 , respectively .
|
[] |
The risk of colorectal cancer was significantly higher ( p < 0 . 01 ) in males than females ( 0 . 63 v 0 . 30 and 0 . 84 v 0 . 44 at ages 50 and 60 years , respectively ) .
|
[
{
"offsets": [
12,
29
],
"text": "colorectal cancer",
"type": "Disease"
}
] |
For females there was a high risk of endometrial cancer ( 0 . 5 at age 60 years ) and premenopausal ovarian cancer ( 0 . 2 at 50 years ) .
|
[
{
"offsets": [
37,
55
],
"text": "endometrial cancer",
"type": "Disease"
},
{
"offsets": [
86,
114
],
"text": "premenopausal ovarian cancer",
"type": "Disease"
}
] |
These intersex differences in colorectal cancer risks have implications for screening programmes and for attempts to identify colorectal cancer susceptibility modifiers .
|
[
{
"offsets": [
30,
47
],
"text": "colorectal cancer",
"type": "Disease"
},
{
"offsets": [
126,
143
],
"text": "colorectal cancer",
"type": "Disease"
}
] |
Age of onset in Huntington disease : sex specific influence of apolipoprotein E genotype and normal CAG repeat length .
|
[
{
"offsets": [
16,
34
],
"text": "Huntington disease",
"type": "Disease"
}
] |
Age of onset ( AO ) of Huntington disease ( HD ) is known to be correlated with the length of an expanded CAG repeat in the HD gene .
|
[
{
"offsets": [
23,
41
],
"text": "Huntington disease",
"type": "Disease"
},
{
"offsets": [
44,
46
],
"text": "HD",
"type": "Disease"
},
{
"offsets": [
124,
126
],
"text": "HD",
"type": "Disease"
}
] |
Apolipoprotein E ( APOE ) genotype , in turn , is known to influence AO in Alzheimer disease , rendering the APOE gene a likely candidate to affect AO in other neurological diseases too .
|
[
{
"offsets": [
75,
92
],
"text": "Alzheimer disease",
"type": "Disease"
},
{
"offsets": [
160,
181
],
"text": "neurological diseases",
"type": "Disease"
}
] |
We therefore determined APOE genotype and normal CAG repeat length in the HD gene for 138 HD patients who were previously analysed with respect to CAG repeat length .
|
[
{
"offsets": [
74,
76
],
"text": "HD",
"type": "Disease"
},
{
"offsets": [
90,
92
],
"text": "HD",
"type": "Disease"
}
] |
Genotyping for APOE was performed blind to clinical information .
|
[] |
In addition to highlighting the effect of the normal repeat length upon AO in maternally inherited HD and in male patients , we show that the APOE epsilon2epsilon3 genotype is associated with significantly earlier AO in males than in females .
|
[
{
"offsets": [
99,
101
],
"text": "HD",
"type": "Disease"
}
] |
Such a sex difference in AO was not apparent for any of the other APOE genotypes .
|
[] |
Our findings suggest that subtle differences in the course of the neurodegeneration in HD may allow interacting genes to exert gender specific effects upon AO .
|
[
{
"offsets": [
66,
83
],
"text": "neurodegeneration",
"type": "Disease"
},
{
"offsets": [
87,
89
],
"text": "HD",
"type": "Disease"
}
] |
Familial deficiency of the seventh component of complement associated with recurrent bacteremic infections due to Neisseria .
|
[
{
"offsets": [
0,
58
],
"text": "Familial deficiency of the seventh component of complement",
"type": "Disease"
},
{
"offsets": [
85,
123
],
"text": "bacteremic infections due to Neisseria",
"type": "Disease"
}
] |
The serum of a 29 - year old woman with a recent episode of disseminated gonococcal infection and a history of meningococcal meningitis and arthritis as a child was found to lack serum hemolytic complement activity .
|
[
{
"offsets": [
60,
93
],
"text": "disseminated gonococcal infection",
"type": "Disease"
},
{
"offsets": [
111,
135
],
"text": "meningococcal meningitis",
"type": "Disease"
},
{
"offsets": [
140,
149
],
"text": "arthritis",
"type": "Disease"
}
] |
The seventh component of complement ( C7 ) was not detected by functional or immunochemical assays , whereas other components were normal by hemolytic and immunochemical assessment .
|
[] |
Her fresh serum lacked complement - mediated bactericidal activity against Neisseria gonorrhoeae , but the addition of fresh normal serum or purified C7 restored bactericidal activity as well as hemolytic activity .
|
[] |
The absence of functional C7 activity could not be accounted for on the basis of an inhibitor .
|
[
{
"offsets": [
4,
28
],
"text": "absence of functional C7",
"type": "Disease"
}
] |
Opsonization and generation of chemotactic activity functioned normally .
|
[] |
Complete absence of C7 was also found in one sibling who had the clinical syndrome of meningococcal meningitis and arthritis as a child and in this siblings clinically well eight - year - old son .
|
[
{
"offsets": [
0,
22
],
"text": "Complete absence of C7",
"type": "Disease"
},
{
"offsets": [
86,
110
],
"text": "meningococcal meningitis",
"type": "Disease"
},
{
"offsets": [
115,
124
],
"text": "arthritis",
"type": "Disease"
}
] |
HLA histocompatibility typing of the family members did not demonstrate evidence for genetic linkage of C7 deficiency with the major histocompatibility loci .
|
[
{
"offsets": [
104,
117
],
"text": "C7 deficiency",
"type": "Disease"
}
] |
This report represents the first cases of C7 deficiency associated with infectious complications and suggests that bactericidal activity may be important in host defense against bacteremic neisseria infections .
|
[
{
"offsets": [
42,
55
],
"text": "C7 deficiency",
"type": "Disease"
},
{
"offsets": [
178,
209
],
"text": "bacteremic neisseria infections",
"type": "Disease"
}
] |
Increased incidence of cancer in patients with cartilage - hair hypoplasia .
|
[
{
"offsets": [
23,
29
],
"text": "cancer",
"type": "Disease"
},
{
"offsets": [
47,
74
],
"text": "cartilage - hair hypoplasia",
"type": "Disease"
}
] |
OBJECTIVE Previous reports have suggested an increased risk of cancer among patients with cartilage - hair hypoplasia ( CHH ) .
|
[
{
"offsets": [
63,
69
],
"text": "cancer",
"type": "Disease"
},
{
"offsets": [
90,
117
],
"text": "cartilage - hair hypoplasia",
"type": "Disease"
},
{
"offsets": [
120,
123
],
"text": "CHH",
"type": "Disease"
}
] |
This study was carried out to further evaluate this risk among patients with CHH and their first - degree relatives .
|
[
{
"offsets": [
77,
80
],
"text": "CHH",
"type": "Disease"
}
] |
STUDY DESIGN One hundred twenty - two patients with CHH were identified through 2 countrywide epidemiologic surveys in 1974 and in 1986 .
|
[
{
"offsets": [
52,
55
],
"text": "CHH",
"type": "Disease"
}
] |
Their parents and nonaffected siblings were identified through the Population Register Center .
|
[] |
This cohort underwent follow - up for cancer incidence through the Finnish Cancer Registry to the end of 1995 .
|
[
{
"offsets": [
38,
44
],
"text": "cancer",
"type": "Disease"
}
] |
RESULTS A statistically significant excess risk of cancer was seen among the patients with CHH ( standardized incidence ratio 6 . 9 , 95 % confidence interval 2 . 3 to 16 ) , which was mainly attributable to non - Hodgkins lymphoma ( standardized incidence ratio 90 , 95 % confidence interval 18 to 264 ) .
|
[
{
"offsets": [
51,
57
],
"text": "cancer",
"type": "Disease"
},
{
"offsets": [
91,
94
],
"text": "CHH",
"type": "Disease"
},
{
"offsets": [
208,
231
],
"text": "non - Hodgkins lymphoma",
"type": "Disease"
}
] |
In addition , a significant excess risk of basal cell carcinoma was seen ( standardized incidence ratio 35 , 95 % confidence interval 7 . 2 to 102 ) .
|
[
{
"offsets": [
43,
63
],
"text": "basal cell carcinoma",
"type": "Disease"
}
] |
The cancer incidence among the siblings or the parents did not differ from the average cancer incidence in the Finnish population .
|
[
{
"offsets": [
4,
10
],
"text": "cancer",
"type": "Disease"
},
{
"offsets": [
87,
93
],
"text": "cancer",
"type": "Disease"
}
] |
CONCLUSIONS This study confirms an increased risk of cancer , especially non - Hodgkins lymphoma , probably attributable to defective immunity , among patients with CHH .
|
[
{
"offsets": [
53,
59
],
"text": "cancer",
"type": "Disease"
},
{
"offsets": [
73,
96
],
"text": "non - Hodgkins lymphoma",
"type": "Disease"
},
{
"offsets": [
165,
168
],
"text": "CHH",
"type": "Disease"
}
] |
Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency .
|
[
{
"offsets": [
40,
82
],
"text": "dihydropyrimidine dehydrogenase deficiency",
"type": "Disease"
}
] |
Dihydropyrimidine dehydrogenase ( DPD ) deficiency is an autosomal recessive disease characterised by thymine - uraciluria in homozygous deficient patients and has been associated with a variable clinical phenotype .
|
[
{
"offsets": [
0,
50
],
"text": "Dihydropyrimidine dehydrogenase ( DPD ) deficiency",
"type": "Disease"
},
{
"offsets": [
57,
84
],
"text": "autosomal recessive disease",
"type": "Disease"
}
] |
In order to understand the genetic and phenotypic basis for DPD deficiency , we have reviewed 17 families presenting 22 patients with complete deficiency of DPD .
|
[
{
"offsets": [
60,
74
],
"text": "DPD deficiency",
"type": "Disease"
},
{
"offsets": [
143,
160
],
"text": "deficiency of DPD",
"type": "Disease"
}
] |
In this group of patients , 7 different mutations have been identified , including 2 deletions [ 295 - 298delTCAT , 1897delC ] , 1 splice - site mutation [ IVS14 + 1G > A ) ] and 4 missense mutations ( 85T > C , 703C > T , 2658G > A , 2983G > T ) .
|
[] |
Analysis of the prevalence of the various mutations among DPD patients has shown that the G - - > A point mutation in the invariant splice donor site is by far the most common ( 52 % ) , whereas the other six mutations are less frequently observed .
|
[
{
"offsets": [
58,
61
],
"text": "DPD",
"type": "Disease"
}
] |
A large phenotypic variability has been observed , with convulsive disorders , motor retardation and mental retardation being the most abundant manifestations .
|
[
{
"offsets": [
56,
76
],
"text": "convulsive disorders",
"type": "Disease"
},
{
"offsets": [
79,
96
],
"text": "motor retardation",
"type": "Disease"
},
{
"offsets": [
101,
119
],
"text": "mental retardation",
"type": "Disease"
}
] |
A clear correlation between the genotype and phenotype has not been established .
|
[] |
An altered beta - alanine , uracil and thymine homeostasis might underlie the various clinical abnormalities encountered in patients with DPD deficiency .
|
[
{
"offsets": [
86,
108
],
"text": "clinical abnormalities",
"type": "Disease"
},
{
"offsets": [
138,
152
],
"text": "DPD deficiency",
"type": "Disease"
}
] |
Fibroblast growth factor homologous factor 2 ( FHF2 ) : gene structure , expression and mapping to the Borjeson - Forssman - Lehmann syndrome region in Xq26 delineated by a duplication breakpoint in a BFLS - like patient .
|
[
{
"offsets": [
103,
141
],
"text": "Borjeson - Forssman - Lehmann syndrome",
"type": "Disease"
},
{
"offsets": [
201,
205
],
"text": "BFLS",
"type": "Disease"
}
] |
Borjeson - Forssman - Lehmann syndrome ( BFLS ) is a syndromal X - linked mental retardation , which maps by linkage to the q26 region of the human X chromosome .
|
[
{
"offsets": [
0,
38
],
"text": "Borjeson - Forssman - Lehmann syndrome",
"type": "Disease"
},
{
"offsets": [
41,
45
],
"text": "BFLS",
"type": "Disease"
},
{
"offsets": [
63,
92
],
"text": "X - linked mental retardation",
"type": "Disease"
}
] |
We have identified a male patient with BFLS - like features and a duplication , 46 , Y , dup ( X ) ( q26q28 ) , inherited from his phenotypically normal mother .
|
[
{
"offsets": [
39,
43
],
"text": "BFLS",
"type": "Disease"
}
] |
Fluorescence in situ hybridisation using yeast artificial chromosome clones from Xq26 localised the duplication breakpoint to an approximately 400 - kb interval in the Xq26 .
|
[] |
3 region between DXS155 and DXS294 / DXS730 .
|
[] |
Database searches and analysis of available genomic DNA sequence from the region revealed the presence of the fibroblast growth factor homologous factor gene , FHF2 , within the duplication breakpoint interval .
|
[] |
The gene structure of FHF2 was determined and two new exons were identified , including a new 5 end exon , 1B .
|
[] |
FHF2 is a large gene extending over approximately 200 kb in Xq26 .
|
[] |
3 and is composed of at least seven exons .
|
[] |
It shows tissue - specific alternative splicing and alternative transcription starts .
|
[] |
Northern blot hybridisation showed highest expression in brain and skeletal muscle .
|
[] |
The FHF2 gene localisation and tissue - specific expression pattern suggest it to be a candidate gene for familial cases of the BFLS syndrome and other syndromal and non - specific forms of X - linked mental retardation mapping to the region .
|
[
{
"offsets": [
128,
141
],
"text": "BFLS syndrome",
"type": "Disease"
},
{
"offsets": [
190,
219
],
"text": "X - linked mental retardation",
"type": "Disease"
}
] |
Germline E - cadherin gene ( CDH1 ) mutations predispose to familial gastric cancer and colorectal cancer .
|
[
{
"offsets": [
60,
83
],
"text": "familial gastric cancer",
"type": "Disease"
},
{
"offsets": [
88,
105
],
"text": "colorectal cancer",
"type": "Disease"
}
] |
Inherited mutations in the E - cadherin gene ( CDH1 ) were described recently in three Maori kindreds with familial gastric cancer .
|
[
{
"offsets": [
107,
130
],
"text": "familial gastric cancer",
"type": "Disease"
}
] |
Familial gastric cancer is genetically heterogeneous and it is not clear what proportion of gastric cancer susceptibility in non - Maori populations is due to germline CDH1 mutations .
|
[
{
"offsets": [
0,
23
],
"text": "Familial gastric cancer",
"type": "Disease"
},
{
"offsets": [
92,
106
],
"text": "gastric cancer",
"type": "Disease"
}
] |
Therefore , we screened eight familial gastric cancer kindreds of British and Irish origin for germline CDH1 mutations , by SSCP analysis of all 16 exons and flanking sequences .
|
[
{
"offsets": [
30,
53
],
"text": "familial gastric cancer",
"type": "Disease"
}
] |
Each family contained ( i ) two cases of gastric cancer in first degree relatives with one affected before age 50 years ; or ( ii ) three or more cases of gastric cancer .
|
[
{
"offsets": [
41,
55
],
"text": "gastric cancer",
"type": "Disease"
},
{
"offsets": [
155,
169
],
"text": "gastric cancer",
"type": "Disease"
}
] |
Novel germline CDH1 mutations ( a nonsense and a splice site ) were detected in two families ( 25 % ) .
|
[] |
Both mutations were predicted to truncate the E - cadherin protein in the signal peptide domain .
|
[] |
In one family there was evidence of non - penetrance and susceptibility to both gastric and colorectal cancer ; thus , in addition to six cases of gastric cancer , a CDH1 mutation carrier developed colorectal cancer at age 30 years .
|
[
{
"offsets": [
80,
109
],
"text": "gastric and colorectal cancer",
"type": "Disease"
},
{
"offsets": [
147,
161
],
"text": "gastric cancer",
"type": "Disease"
},
{
"offsets": [
198,
215
],
"text": "colorectal cancer",
"type": "Disease"
}
] |
We have confirmed that germline mutations in the CDH1 gene cause familial gastric cancer in non - Maori populations .
|
[
{
"offsets": [
65,
88
],
"text": "familial gastric cancer",
"type": "Disease"
}
] |
However , only a minority of familial gastric cancers can be accounted for by CDH1 mutations .
|
[
{
"offsets": [
38,
53
],
"text": "gastric cancers",
"type": "Disease"
}
] |
Loss of E - cadherin function has been implicated in the pathogenesis of sporadic colorectal and other cancers , and our findings provide evidence that germline CDH1 mutations predispose to early onset colorectal cancer .
|
[
{
"offsets": [
82,
110
],
"text": "colorectal and other cancers",
"type": "Disease"
},
{
"offsets": [
202,
219
],
"text": "colorectal cancer",
"type": "Disease"
}
] |
Thus , CDH1 should be investigated as a cause of inherited susceptibility to both gastric and colorectal cancers .
|
[
{
"offsets": [
82,
112
],
"text": "gastric and colorectal cancers",
"type": "Disease"
}
] |
A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys - Drash syndrome .
|
[
{
"offsets": [
69,
93
],
"text": "urogenital abnormalities",
"type": "Disease"
},
{
"offsets": [
97,
119
],
"text": "Denys - Drash syndrome",
"type": "Disease"
}
] |
The Wilms tumor - suppressor gene , WT1 , plays a key role in urogenital development , and WT1 dysfunction is implicated in both neoplastic ( Wilms tumor , mesothelioma , leukemias , and breast cancer ) and nonneoplastic ( glomerulosclerosis ) disease .
|
[
{
"offsets": [
4,
15
],
"text": "Wilms tumor",
"type": "Disease"
},
{
"offsets": [
91,
106
],
"text": "WT1 dysfunction",
"type": "Disease"
},
{
"offsets": [
129,
139
],
"text": "neoplastic",
"type": "Disease"
},
{
"offsets": [
142,
153
],
"text": "Wilms tumor",
"type": "Disease"
},
{
"offsets": [
156,
168
],
"text": "mesothelioma",
"type": "Disease"
},
{
"offsets": [
171,
180
],
"text": "leukemias",
"type": "Disease"
},
{
"offsets": [
187,
200
],
"text": "breast cancer",
"type": "Disease"
},
{
"offsets": [
207,
220
],
"text": "nonneoplastic",
"type": "Disease"
},
{
"offsets": [
223,
241
],
"text": "glomerulosclerosis",
"type": "Disease"
}
] |
The analysis of diseases linked specifically with WT1 mutations , such as Denys - Drash syndrome ( DDS ) , can provide valuable insight concerning the role of WT1 in development and disease .
|
[
{
"offsets": [
74,
96
],
"text": "Denys - Drash syndrome",
"type": "Disease"
},
{
"offsets": [
99,
102
],
"text": "DDS",
"type": "Disease"
}
] |
DDS is a rare childhood disease characterized by a nephropathy involving mesangial sclerosis , XY pseudohermaphroditism , and / or Wilms tumor ( WT ) .
|
[
{
"offsets": [
0,
3
],
"text": "DDS",
"type": "Disease"
},
{
"offsets": [
51,
62
],
"text": "nephropathy",
"type": "Disease"
},
{
"offsets": [
73,
92
],
"text": "mesangial sclerosis",
"type": "Disease"
},
{
"offsets": [
98,
119
],
"text": "pseudohermaphroditism",
"type": "Disease"
},
{
"offsets": [
131,
142
],
"text": "Wilms tumor",
"type": "Disease"
},
{
"offsets": [
145,
147
],
"text": "WT",
"type": "Disease"
}
] |
DDS patients are constitutionally heterozygous for exonic point mutations in WT1 , which include mutations predicted to truncate the protein within the C - terminal zinc finger ( ZF ) region .
|
[
{
"offsets": [
0,
3
],
"text": "DDS",
"type": "Disease"
}
] |
We report that heterozygosity for a targeted murine Wt1 allele , Wt1 ( tmT396 ) , which truncates ZF3 at codon 396 , induces mesangial sclerosis characteristic of DDS in adult heterozygous and chimeric mice .
|
[
{
"offsets": [
125,
144
],
"text": "mesangial sclerosis",
"type": "Disease"
},
{
"offsets": [
163,
166
],
"text": "DDS",
"type": "Disease"
}
] |
Male genital defects also were evident and there was a single case of Wilms tumor in which the transcript of the nontargeted allele showed an exon 9 skipping event , implying a causal link between Wt1 dysfunction and Wilms tumorigenesis in mice .
|
[
{
"offsets": [
0,
20
],
"text": "Male genital defects",
"type": "Disease"
},
{
"offsets": [
70,
81
],
"text": "Wilms tumor",
"type": "Disease"
},
{
"offsets": [
197,
212
],
"text": "Wt1 dysfunction",
"type": "Disease"
},
{
"offsets": [
217,
236
],
"text": "Wilms tumorigenesis",
"type": "Disease"
}
] |
However , the mutant WT1 ( tmT396 ) protein accounted for only 5 % of WT1 in both heterozygous embryonic stem cells and the WT .
|
[
{
"offsets": [
124,
126
],
"text": "WT",
"type": "Disease"
}
] |
This has implications regarding the mechanism by which the mutant allele exerts its effect .
|
[] |
Mechanism of increased iron absorption in murine model of hereditary hemochromatosis : increased duodenal expression of the iron transporter DMT1 .
|
[
{
"offsets": [
58,
84
],
"text": "hereditary hemochromatosis",
"type": "Disease"
}
] |
Hereditary hemochromatosis ( HH ) is a common autosomal recessive disorder characterized by tissue iron deposition secondary to excessive dietary iron absorption .
|
[
{
"offsets": [
0,
26
],
"text": "Hereditary hemochromatosis",
"type": "Disease"
},
{
"offsets": [
29,
31
],
"text": "HH",
"type": "Disease"
},
{
"offsets": [
46,
74
],
"text": "autosomal recessive disorder",
"type": "Disease"
}
] |
We recently reported that HFE , the protein defective in HH , was physically associated with the transferrin receptor ( TfR ) in duodenal crypt cells and proposed that mutations in HFE attenuate the uptake of transferrin - bound iron from plasma by duodenal crypt cells , leading to up - regulation of transporters for dietary iron .
|
[
{
"offsets": [
57,
59
],
"text": "HH",
"type": "Disease"
}
] |
Here , we tested the hypothesis that HFE - / - mice have increased duodenal expression of the divalent metal transporter ( DMT1 ) .
|
[] |
By 4 weeks of age , the HFE - / - mice demonstrated iron loading when compared with HFE + / + littermates , with elevated transferrin saturations ( 68 . 4 % vs . 49 . 8 % ) and elevated liver iron concentrations ( 985 micrograms vs . 381 micrograms ) .
|
[] |
By using Northern blot analyses , we quantitated duodenal expression of both classes of DMT1 transcripts one containing an iron responsive element ( IRE ) , called DMT1 ( IRE ) , and one containing no IRE , called DMT1 ( non - IRE ) .
|
[] |
End of preview. Expand
in Data Studio
README.md exists but content is empty.
- Downloads last month
- 36